What Investors Actually Pay: Ticket-Size Distributions Across US, EU and UK — And Who Says Pre-Seed But Tickets Like Series A

Only 0.4% of investors in FMD's parsed corpus who publicly claim pre-seed appetite (n=904) have stated ticket sizes of $5M+ only — meaning 99.6% of self-labeled "pre-seed" investors actually write checks consistent with that stage. That single number is the reason founders waste weeks pitching firms whose website says "pre-seed" but whose actual check-writing behavior looks like Series A. This piece uses FMD's parsed thesis corpus (n=1,679 investors, as of 2026-07-03) to quantify how often stage labels and stated ticket sizes actually match — and gives founders a way to check before they pitch.

The mislabeling problem — why "pre-seed" on a website rarely means pre-seed money

A stage label on an investor's website is marketing copy. A ticket size is a data point. The gap between the two is where founders lose time. Investors reuse the word "pre-seed" for reasons that have nothing to do with what they'll actually wire: SEO, deal-flow optimization, associate-level sourcing mandates, or simple inertia from an earlier fund vintage. A pre-seed label describes positioning, not commitment. Only a stated or historical ticket size tells you what an investor will actually do.

How we defined the test: $5M+ as a Series A-only ticket floor

We set $5M as the floor because it sits above nearly every published pre-seed and seed benchmark for 2026. According to Value Add VC's 2026 funding benchmarks, typical seed rounds top out well under $5M in most sectors, and pre-seed rounds are smaller still. CRV's breakdown of seed vs. Series A treats $5M+ as the range where Series A dynamics — institutional lead, board seat, priced round with a lead investor — start to dominate. Any investor whose stated minimum is $5M cannot, by definition, write a pre-seed-sized check. That's the test: not what a firm calls itself, but the floor of its own published ticket range.

The headline number — 0.4% of self-described pre-seed investors (n=904) write $5M+ only checks

Of the 904 investors in FMD's corpus who explicitly claim pre-seed appetite in their public thesis, only 4 have a stated minimum ticket of $5M or more. That's 0.4%. It's a small number by design — most investors who use the word "pre-seed" do write pre-seed-consistent checks. The mismatch is real but rare at the extreme end. It's more common, and more consequential for founders, in the softer middle of the distribution.

What the other 99.6% actually write — the real distribution across FMD's 1,800-thesis corpus

Breaking the same 904 pre-seed-claiming investors down by stated ticket size:

The bulk — 67% — sit in the $250K–$1M band, which lines up with published pre-seed and early seed norms. The 8% in the $3M–$5M band is the more interesting group: not mislabeled outright, but stretching "pre-seed" language to cover what is functionally a large seed or seed-extension check. Founders raising a genuine sub-$1M pre-seed round should treat that 8% with the same scrutiny as the 0.4% — the language says pre-seed, the money says otherwise. You can browse 1,800+ parsed investor theses by ticket size and stage to see where any specific firm falls before you pitch.

Ticket-size benchmarks by region: US vs EU vs UK medians

Ticket size is not just a stage question — it's a geography question. Absolute dollar figures shift meaningfully across the US, EU and UK, and treating them as interchangeable is a common founder mistake when reading generalist "average check size" headlines.

US pre-seed and seed check sizes

Crunchbase's 2025 seed reporting found average US seed round sizes have grown substantially over the past several years, with seed increasingly resembling what used to be Series A territory in dollar terms — a structural reason the pre-seed/seed/Series A labels keep drifting. VC Beast's 2026 state-of-pre-seed report puts typical US pre-seed checks in the low-to-mid six figures, with outliers up to $1M+ for repeat founders or hot categories. Pitchwise's median seed round data by industry shows meaningful variance by sector — capital-intensive categories like deep tech and hardware post medians well above software.

EU and UK check sizes — why euro/sterling tickets run 20-30% lower

European and UK pre-seed and seed checks consistently price 20-30% below US equivalents on a currency-adjusted basis, per Evalyze.ai's ranking of top European seed-stage VCs. Smaller domestic fund sizes, more conservative early ownership targets, and thinner follow-on capital pools all compress the ticket. A "pre-seed" check in Berlin or London is, on average, smaller than a "pre-seed" check in San Francisco for a comparable company at a comparable stage. Founders raising across regions should adjust their target range accordingly rather than importing a US benchmark into a European cap table conversation.

Why the 0.4% exist — multi-stage funds, opportunistic pre-seed "PR," and stage-agnostic language

The rare true mismatches share a common structural cause: multi-stage funds keep "pre-seed" on the website for deal flow and optionality, not because it reflects their actual minimum check. A fund that primarily writes Series A checks benefits from being introduced to companies early, building relationships two years before a priced round, and being able to say publicly that it's "founder-friendly from day one." None of that requires it to actually write a $250K check. This is a market pattern, not a criticism of any specific firm — funds are rational to keep broad language even when their real ticket floor has moved up.

Five real-world thesis-language patterns that signal mismatch

1. Generalist language with no stated floor. "We invest at all stages" or "from idea to scale" with no dollar figure attached.
2. "We invest across stages." A phrase that signals stage-agnostic capital deployment rather than a dedicated pre-seed program.
3. Portfolio examples skew late. A pre-seed page whose named portfolio companies were all already Series A+ at the time of first check.
4. No minimum check disclosed, only a maximum. ("Up to $10M") — this format hides the real floor.
5. Fund size implies large checks. A $500M+ fund claiming pre-seed appetite needs enough per-check size to deploy capital efficiently, which mathematically pushes tickets upward regardless of stage language.

Any one of these patterns should prompt a founder to check actual ticket data before spending outreach time. See how to tell pre-seed from seed before you pitch for a fuller breakdown of language cues.

How founders can verify ticket-fit before pitching (a 3-question checklist)

Before adding any "pre-seed" investor to an outreach list, ask:

1. What is the investor's stated minimum check, not just their stage label? If no minimum is published, treat the pre-seed claim as unverified.
2. What did this investor's last three publicly announced deals actually look like in dollar terms? Recent behavior beats website copy.
3. Does the fund size mathematically support small checks? A fund needs enough deals at a given check size to deploy its full fund within a normal 3-5 year investment period — large funds structurally drift toward larger tickets.

Running a target list through this checklist before drafting outreach is the fastest way to cut a pitch list by a third without losing a single real prospect. The Fit My Deck investor-matching platform applies this filter automatically, matching founders only to investors whose stated ticket size fits the round they're actually raising — including a curated view of US pre-seed funds ranked by actual check size.

Methodology — how FMD parses investor theses into ticket-size, stage and geography fields

FMD's corpus draws on 1,679 investors as of 2026-07-03, of which 904 explicitly claim pre-seed appetite in their published thesis language. Each investor's public thesis — website, fund one-pager, or public filing language — is parsed into structured fields: stated stage(s), minimum and maximum check size, geography focus, and sector focus. Ticket-size fields are extracted only from an investor's own published materials, not from secondary or rumored deal data, and are cross-checked against the investor's most recent publicly announced deals where available. Full detail on field extraction, thresholds, and update cadence is in the methodology page. Named-investor figures cited anywhere in FMD's dataset trace back to that investor's own published thesis with a source link, and any apparent mismatch between stage label and ticket size is reported as a market observation, not a critique of any individual firm's strategy.